Highlights and Quick Summary
- Equity Repurchase (Common, Net) for the quarter ending February 28, 2023 was $2.2 Thousand (a -40.54% decrease compared to previous quarter)
- Year-over-year quarterly Equity Repurchase (Common, Net) decreased by -31.25%
- Annual Equity Repurchase (Common, Net) for 2022 was $5.05 Million (a -97.2% decrease from previous year)
- Annual Equity Repurchase (Common, Net) for 2021 was $180 Million (a 139.63% increase from previous year)
- Annual Equity Repurchase (Common, Net) for 2020 was $75.2 Million (a 183.6% increase from previous year)
- Twelve month Equity Repurchase (Common, Net) ending February 28, 2023 was $33.1 Thousand (a -99.34% decrease compared to previous quarter)
- Twelve month trailing Equity Repurchase (Common, Net) decreased by -100.07% year-over-year
Trailing Equity Repurchase (Common, Net) for the last four month:
| 28 Feb '23 | 30 Nov '22 | 31 Aug '22 | 31 May '22 |
|---|---|---|---|
| $33.1 Thousand | $5.04 Million | $5.05 Million | $-48.5 Million |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Equity Repurchase (Common, Net) of Organigram Holdings Inc.
Most recent Equity Repurchase (Common, Net)of OGI including historical data for past 10 years.Interactive Chart of Equity Repurchase (Common, Net) of Organigram Holdings Inc.
Organigram Holdings Inc. Equity Repurchase (Common, Net) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $0.0 | – | – | – | – |
| 2022 | $0.0 | $0.02 | $0.0 | $5.01 | $5.05 |
| 2021 | $0.01 | $-53.54 | $228.2 | $-43.83 | $180.16 |
| 2020 | $49.33 | $15.34 | $19.01 | $40.8 | $75.18 |
| 2019 | $0.03 | $7.19 | $11.35 | $4.56 | $26.51 |
| 2018 | $3.42 | – | – | – | $5.23 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic